GB1567307A - Salts of glycyrrhizinic acid - Google Patents
Salts of glycyrrhizinic acid Download PDFInfo
- Publication number
- GB1567307A GB1567307A GB4965475A GB4965475A GB1567307A GB 1567307 A GB1567307 A GB 1567307A GB 4965475 A GB4965475 A GB 4965475A GB 4965475 A GB4965475 A GB 4965475A GB 1567307 A GB1567307 A GB 1567307A
- Authority
- GB
- United Kingdom
- Prior art keywords
- ammonium
- glycyrrhizinate
- tetradecyl
- compounds
- quaternary ammonium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 title description 25
- 229960004949 glycyrrhizic acid Drugs 0.000 title description 7
- 235000019410 glycyrrhizin Nutrition 0.000 title description 7
- 150000003839 salts Chemical class 0.000 title description 3
- 150000001875 compounds Chemical class 0.000 claims description 33
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 11
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- 239000004215 Carbon black (E152) Substances 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Natural products C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 2
- 229930195733 hydrocarbon Natural products 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims 1
- 229940074774 glycyrrhizinate Drugs 0.000 description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- 239000000047 product Substances 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- 239000000203 mixture Substances 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 13
- 239000000606 toothpaste Substances 0.000 description 11
- WNBGYVXHFTYOBY-UHFFFAOYSA-N benzyl-dimethyl-tetradecylazanium Chemical compound CCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 WNBGYVXHFTYOBY-UHFFFAOYSA-N 0.000 description 10
- 235000019441 ethanol Nutrition 0.000 description 10
- -1 saturated acyclic hydrocarbon radical Chemical class 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 230000000844 anti-bacterial effect Effects 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 230000007794 irritation Effects 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- CXRFDZFCGOPDTD-UHFFFAOYSA-M Cetrimide Chemical compound [Br-].CCCCCCCCCCCCCC[N+](C)(C)C CXRFDZFCGOPDTD-UHFFFAOYSA-M 0.000 description 8
- 229940034610 toothpaste Drugs 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 239000000551 dentifrice Substances 0.000 description 6
- FSIALNWCGBLSCY-UHFFFAOYSA-N dodecyl-dimethyl-(naphthalen-1-ylmethyl)azanium Chemical compound C1=CC=C2C(C[N+](C)(C)CCCCCCCCCCCC)=CC=CC2=C1 FSIALNWCGBLSCY-UHFFFAOYSA-N 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 235000019605 sweet taste sensations Nutrition 0.000 description 6
- GLFDLEXFOHUASB-UHFFFAOYSA-N trimethyl(tetradecyl)azanium Chemical compound CCCCCCCCCCCCCC[N+](C)(C)C GLFDLEXFOHUASB-UHFFFAOYSA-N 0.000 description 6
- SIHFYNZIBKOFFK-UHFFFAOYSA-N 1-tetradecylpyridin-1-ium Chemical compound CCCCCCCCCCCCCC[N+]1=CC=CC=C1 SIHFYNZIBKOFFK-UHFFFAOYSA-N 0.000 description 5
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 230000002882 anti-plaque Effects 0.000 description 4
- 229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 4
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 4
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 3
- RNFNQLZKGXXDBL-UHFFFAOYSA-M [OH-].C(CCCCCCCCCCCCC)[N+]1=CC=CC=C1 Chemical compound [OH-].C(CCCCCCCCCCCCC)[N+]1=CC=CC=C1 RNFNQLZKGXXDBL-UHFFFAOYSA-M 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000002324 mouth wash Substances 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 238000004448 titration Methods 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 2
- 229910021502 aluminium hydroxide Inorganic materials 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 2
- 229940038472 dicalcium phosphate Drugs 0.000 description 2
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- PPNHCZHNVOCMHS-UHFFFAOYSA-M trimethyl(tetradecyl)azanium;hydroxide Chemical compound [OH-].CCCCCCCCCCCCCC[N+](C)(C)C PPNHCZHNVOCMHS-UHFFFAOYSA-M 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- HJNAJKBRYDFICV-UHFFFAOYSA-M 1-tetradecylpyridin-1-ium;bromide Chemical compound [Br-].CCCCCCCCCCCCCC[N+]1=CC=CC=C1 HJNAJKBRYDFICV-UHFFFAOYSA-M 0.000 description 1
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical compound [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 description 1
- WLDHEUZGFKACJH-ZRUFZDNISA-K Amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1\N=N\C1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-ZRUFZDNISA-K 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 125000006177 alkyl benzyl group Chemical group 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000005501 benzalkonium group Chemical group 0.000 description 1
- AGYULCVGTMTHPE-UHFFFAOYSA-N benzyl(methyl)azanium;hydroxide Chemical compound [OH-].C[NH2+]CC1=CC=CC=C1 AGYULCVGTMTHPE-UHFFFAOYSA-N 0.000 description 1
- OCBHHZMJRVXXQK-UHFFFAOYSA-M benzyl-dimethyl-tetradecylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 OCBHHZMJRVXXQK-UHFFFAOYSA-M 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 150000001767 cationic compounds Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 1
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical compound C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011737 fluorine Chemical group 0.000 description 1
- 229910052731 fluorine Chemical group 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- GUQRKZPMVLRXLT-UHFFFAOYSA-N n-cyclohexylhydroxylamine Chemical compound ONC1CCCCC1 GUQRKZPMVLRXLT-UHFFFAOYSA-N 0.000 description 1
- 229940100662 nasal drops Drugs 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 229940112041 peripherally acting muscle relaxants other quaternary ammonium compound in atc Drugs 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- ROSDSFDQCJNGOL-UHFFFAOYSA-N protonated dimethyl amine Natural products CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/256—Polyterpene radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Description
(54) SALTS OF GLYCYRRHIZINIC ACID
(71) We, UNILEVER LIMITED, a company organised under the laws of
Great Britain, of Unilever House, Blackfriars, London E/C 4, England, do hereby declare the invention for which we pray that a patent may be granted to us and the method by which it is to be performed, to be particularly described in and by the following statement:- The invention is concerned with compounds having a bactericidal effect and a sweet taste which can be used in cosmetic compositions, in particular for oral use. More particularly the invention is concerned with the chemical combination of quaternary ammonium compounds with glycyrrhizinic acid.
The quaternary ammonium compounds are classified as cationic compounds having a bactericidal effect. Those with long chains are surfactants and are used in haircare products, for cleaning in the food industries and in medicine as disinfectants.
Although, in certain formulations, when mixed with nonionics, they are barely toxic and barely irritating, their very bitter taste makes it difficult to apply them in products for oral use.
The object of this invention is to prepare novel germicidal compounds of only slight toxidty, only slight irritation and a sweet taste. Besides, the invention is particularly concerned with their use in products for the care of the mouth.
The novel compounds according to the invention are obtained by neutralisation of glycyrrhizinic acid by one, two or three molecules of a quaternary ammonium base.
They are represented by the following general formula:
in which R1, R2 and R, are each hydrogen or ammonium or a quaternary ammonium
cation having the structure
in which R4, R5 and Rt are each a C,, straight or branched chain, saturated or un
saturated acyclic hydrocarbon radical, or two or three of R4, R5 and R6 together
with the adjacent nitrogen atom represent a pyridine, piperidine or morpholine
radical, and R is an alkyl, hydroxyalkyl, aryl, aralkyl, cyclohexyl or hydroxycyclohexyl radical, with the proviso that at least one of R1, R2 and R3 is a quaternary ammonium cation having the above structure and not more than one of the radicals R1-R, is ammonium.
These compounds are obtained by reaction of quaternary ammonium hydroxide with the mono-ammonium salt of glycyrrhizinic acid. The quaternary ammonium hydroxides are prepared in the usual way starting from halogenides. The monoammonium salt of glycyrrhizinic acid is a commercial product, named Glycamil, marketed by the firm of Inverni della Beffa, Milan.
Typical examples of quaternary ammonium compounds suitable for the synthesis of the compounds of the invention are the alkyl trimethyl ammonium halogenides of formula R-N(CH3)nX and the alkyl benzyl dimethyl ammonium halogenides of the formula R-N(CH,). . CH2CGHo . X, in which X represents chlorine, bromine or fluorine and R represents an alkyl radical with 8 to 18 carbon atoms. Other suitable compounds are the alkyl dimethyl (substituted benzyl) ammonium halogenides, the benzyl radical of which has as substituents one or more alkyl groups of 1 to 4 carbon atoms, such as a methyl radical, two methyl radicals, or an ethyl radical.
Various other quaternary ammonium compounds are also suitable, e.g. N-alkyl pyridinium halogenides and N-trialkyl hydroxycyclohexyl ammonium halogenides.
Quaternary ammonium compounds suitable for the preparation of the glycyrrhizinic acid compounds are, e.g. tetradecyl trimethyl ammonium bromide, hexadecyl trimethyl ammonium bromide and benzyl dimethyl alkyl ammonium halogenides such as benzyl dimethyl tetradecyl ammonium chloride.
Evaluation of bactericidal and anti-plaque activity
The bactericidal efficiency can be evaluated by the minimum inhibitory concentration test, in which the lowest concentration of the microbiologically active compound is determined which inhibits the growth of the microorganisms chosen. This is a technique which is known to those skilled in the art.
Test tubes are prepared containing 9 ml of Jordan medium with 1) 2% sucrose, 2) blood serum and 3) 0.4% mucin. The compound of the invention is added at an appropriate concentration to the test tubes. The tubes are then inoculated with 0.2 ml of a twenty-four-hour-old culture of Streptococcus Ingbritt 00101, after which they are incubated at 379C for 48 hours and the evolution of the culture is observed. The results of the tests on four compounds according to the invention, to wit: tetradecyl trimethyl ammonium glycyrrhizinate, N-(tetradecyl)-pyridinium glycyrrhizinate, dodecyl dimethyl naphthylmethyl ammonium glycyrrhizinate and tetradecyl dimethyl benzyl ammonium glycyrrhizinate, compared with the tetradecyl trimethyl ammonium bromide taken as reference, are illustrated by the figures of Table I.
TABLE I
Minimum inhibitory concentration
Media Jordan Jordan + serum Jordan + mucin (%) (%) (%) Tetradecyl trimethyl ammonium bromide < 0.0003 0.006 0.006 Tetradecyl trimethyl ammonium glycyrrhizinate 0.0006 0.006 0.003 N-(Tetradecyl)-pyridinium glycyrrhizinate 0.003 0.03 0.03 Dodecyl dimethyl naphthylmethyl ammonium glycyrrhizinate 0.03 > 0.06 0.06 Tetradecyl dimethyl benzyl ammonium glycyrrhizinate 0.003 0.03 0.03 From Table I it appears that the bactericidal activity of the compounds according to the invention is generally weaker than that of tetradecyl trimethyl ammonium bromide used as reference. This activity is completely satisfactory and sufficient for their use in products for the care of the mouth.
The bactericidal efficiency of the compounds according to the invention can also be evaluated by means of the biophotometer method. With this instrument, the growth curve of a Streptococcus strain (4M4) was followed. In the experiment described here, mono-, di- or tri(tetradecyl dimethyl benzylammonium) glycyrrhizinates were used at a concentration of 2 g per ml of culture medium.
An example of a series of growth curves produced when using this instrument is reproduced in the Figure.
In this figure, the abscissa represents the turbidity of a liquid culture medium con- taining growing bacterial cells, whereas the ordinate represents the passage of time during the experiment.
It will be noted that the control sample grew rapidly after innoculation and reached a maximum as measured turbidimetrically after about four hours.
The growth rate of the sample containing the mono quaternary ammonium salt of glycyrrhizinic acid was only slightly slower than that of the control, probably because this particular salt is only slightly soluble in water.
The growth rates of both of the other samples containing respectively the corresponding di-substituted and tri-substituted quaternary ammonium salts of glycyrrhizinate were both very low and did not reach a maximum value until after 36 hours indicating a strong bacteriostatic effect in both cases.
Examination of the curves also yields evidence that the growth inhibition of the cultures is correlated with the benzalkonium moiety of the molecule: 3.5% for the mono, 4.8% for the di and 5.5% for the tri-salt.
The compounds according to the invention were introduced into several types of toothpaste.
The minimum inhibitory concentrations (MIC) were obtained using aqueous extracts of the toothpastes. Experimental data showed that the bactericidal activity of the compounds according to the invention is the same, at equal concentration, whether in aqueous solution or in a toothpaste, provided the latter is adequately formulated.
For example, the MIC of an aluminium hydroxide toothpaste with 1% di(tetraethyl dimethyl benzylammonium) glycyrrhizinate equals that of a 1% aqueous solution of the same compound.
The bactericidal activity remains unaffected after 6 months' storage of the toothpaste at room temperature or at 40"C.
In vivo tests of anti-plaque activity were carried out in a panel of 7 human subjects.
The experiment reported here involved an aluminium hydroxide toothpaste containing 1% of di(tetradecyl dimethyl benzylammonium) glycyrrhizinate that was tested against a placebo and a positive control. The latter was a toothpaste containing 0.8% of
Hibitane digluconate whose anti-plaque properties are well known but which in a short time produces brownish yellow stains on the teeth.
Anti-plaque activity was assessed over a period of 16 hours. A 0.5% aqueous erythrosin solution was used as disclosing agent.
The results of the statistical analysis (analysis of variance and Duncan's Multiple
Range Test) show a significant difference between the three toothpastes, the confidence level being 95%. The Hibitane toothpaste is significantly more active than the paste containing the compound according to the invention, which is significantly more active than the placebo.
Organoleptic Tests
The organoleptic tests of the four compounds mentioned before were carried out in aqueous or hydroalcoholic solutions of 0.2% by weight. The bitter and sweet tastes were compared with the taste of tetradecyl trimethyl ammonium bromide and evaluated by experts who noted the times during which the tastes were perceived. The results are indicated in Table II.
TABLE II
Organoleptic evaluation
Taste Bitter Sweet Tetradecyl trimethyl ammonium bromide Extremely strong for No sweet taste 1 minute. whatsoever.
Strong for 4 minutes.
Weakens after 5 minutes.
Tetradecyl trimethyl ammonium glycyrrhizinate 1st minute: strong. First 9 minutes: strong.
Weakens after 2 minutes. Medium: 15 minutes.
Weakens after 20 minutes.
N-(Tetradecyl)-pyridinium glycyrrhizinate 1st minute: rather strong. First 7 minutes: strong.
Weakens after 3 minutes. Medium: 15 minutes.
Weakens after 25 minutes.
Dodecyl dimethyl naphthylmethyl ammonium First 2 minutes: strong. Medium: 12 minutes. glycyrrhizinate Weakens after 5 minutes. Weak: 15 minutes.
Weakens after 22 minutes.
Tetradecyl dimethyl benzyl ammonium First 30 seconds: medium. Strong: 4 minutes. glycyrrhizinate Weakens after 2 minutes. Medium: 15 minutes.
Weakens after 20 minutes.
It was observed that the compounds developed a bitter, less intense and less prolonged taste than that of the reference and which is in the case of the compounds according to the invention masked very quickly by an intense and persistens sweet taste.
Skin Irritation Test
The irritation on the skin was tested on rabbits by means of the Liggett subcutaneous injection method. In this test solutions containing 0.5 to 0.01% by weight of the compound to be examined were injected at different places into the shaven skin of several laboratory rabbits (in general 4 for each compound). After 2448, or 72 hours if there was no reaction, the irritation of the skin was determined and expressed as a number. The following reactions were noted: a) erythema, b) oedema, c) dryness, d) cracking, e) peeling. The numerical value corresponding to each case is a) 0.15 (doubtful reaction), b) 0.25 (very slight reaction), c) 0.5 (slight reaction), d) 1 (visible reaction), e) 2 (distinct reaction) and 3 (very serious reaction).
The determination of the irritation of the compounds submitted to the test was made parallel with Vitamin C, 0.5% of which compound is taken as reference. The results are expressed in the ratio:
Irritation due to the compound R -- Irritation due to Vitamin C
TABLE III
Cutaneous irritation
R Tetradecyl trimethyl ammonium bromide 1.16 Tetradecyl trimethyl ammonium glycyrrhizinate 0.75 N-(Tetradecyl)-pyridinium glycyrrhizinate 0.80 Dodecyl dimethyl naphthylmethyl ammonium glycyrrhizinate * Tetradecyl dimethyl benzyl ammonium glycyrrhi zinate 0.49 * Solubility v 0.5: R not determined.
The Table shows that the irritation caused by the reference is distinctly greater than that caused by the quaternary ammonium glycyrrhizinates.
The compounds according to the invention can be used in an effective and sufficient quantity in products in which a bactericidal effect is desired, more particularly in products in which little toxicity, little irritation and a sweet taste are desired.
As examples illustrating the compositions in which the compounds of the invention can be incorporated, can be cited: a) Products for the care of the mouth such as toothpastes, mouthwashes, dentifrices
in powder and solid form, toothpicks, lipsticks. b) Medical products such as gargles, nose-drops. c) Various compositions such as adhesive compositions for envelopes, postage stamps,
labels, foods.
It stands to reason that according to the above-mentioned description the compounds according to the invention and their mixtures can be used in a large number of products that are ingested, consumed or otherwise organoleptically perceived.
The quantity of the compounds of the invention which can be incorporated into such compositions can be adjusted to suit individual requirements. However, by way of example we can mention that of the products for the care of the mouth, it is preferable to employ by weight from 0.05 to 5.0% of the compounds in mouthwashes at a ready for use dilution and similarly from 0.5 to 5.0% in toothpastes or dental creams and from 0.5 to 10% in toothpowders.
It will be appreciated that the compounds of the invention, prepared for example according to the method described hereinbefore, can be the appropriate mono- or dior tri-quaternary ammonium derivatives. Accordingly, it is possible to incorporate in compositions, such as those referred to herein by way of example, any one of these three derivatives or a mixture of any two or indeed all three. It follows that the average degree of substitution by the quatemary ammonium in the molecule of the compound can be any value intermediate 1 and 3, that is intermediate the mono- and the tri-substituted derivatives, depending on the proportion of each which is present in the mixture. For example, a mixture containing equal proportions of the mono and the di substituted compound will have an average degree of substitution of 1.5.
Preferably the degree of substitution is from 1.5 to 2.5, most preferably 2.0, since we have discovered that the mono substituent with a degree of substitution of 1.0) is only slightly soluble in water and therefore is unlikely to have a significantly beneficial effect in products such as dentifrices. Also we have found that the tri-substituent (with a degree of substitution of 3.0) is too basic for use on its own in this type of product.
The following Examples are given to illustrate embodiments of the invention. It goes without saying that the Examples are merely given for illustrative purposes without, however, being limited thereto.
Unless otherwise indicated, all parts, percentages, ratios and proportions given in the present Specification are by weight.
EXAMPLE I.
Preparation of tetradecyl trimethyl ammonium glycyrrhizinate
Preparation of tetradecyl trimethyl ammonium hydroxide
287 g (0.85 mole) tetradecyl trimethyl ammonium bromide (Noramium M 14 sold by the firm of Auby-Prochinor) are dissolved in 11 pure ethanol; 450 ml of a 1.85
N solution of potassium hydroxide are added to pure ethanol. (NORAMIUM is a trade mark). The mixture is allowed to stand for some hours so that the precipitation of the potassium bromide is complete, after which it is removed by filtration.
Preparation of glycyrrhizinate
50 g ammonium glycyrrhizinate (Glycamil) are suspended in 100 ml pure ethyl alcohol, after which 185 ml of a 0.644 N alcoholic solution of tetradecyl trimethyl ammonium hydroxide are added. Dissolution is complete.
This solution is then evaporated. In this way 72 g of a light-brown powder are obtained which softens and decomposes without melting at 2000 C.
UV = E mole A 240 = 8.350.
EXAMPLE II.
Preparation of N- (tetradecyl) -pyridinium glycyrrhizinate
Preparation of N-(tetradecyl)-pyridinium hydroxide
(= myristylpyridinium hydroxide)
A column of a Dowex AG2-X8 resin, diameter of the column 24 mm, height 100 mm, volume 45 ml, i.e. an exchange capacity of about 63 meq. is preferred.
(DOWEX is a trade mark). This resin is then hydroxylated by passing two times through a 500 ml solution of 2 N potassium hydroxide, followed by rinsing with distilled water until neutrality is achieved. The column is then rinsed with 250 ml ethyl alcohol.
6 g myristylpyridinium bromide (16.8 meq), sold by the firm of Schuchardt, are dissolved in 20 ml ethyl alcohol awl.9 placed in the head of the column. The mixture is then eluted by four times 50 ml ethanol. The eluates are collected and completed to 250 ml.
Preparation of glycyrrhizinate
8.4 g (0.01 mole) ammonium glycyrrhizinate (Glycamil )are suspended in 20 ml pure ethyl alcohol; then 30 ml of a 0.067 N solution of myristylpyridinium hydroxide are added, after which dissolution occurs. This solution is then evaporated under vacuum.
Analysis:
The purity is determined by titration of the bound quaternary ammonium, expressed in milli-equivalent for 100 g product.
Found 156.
Calculated 146.
EXAMPLE III.
Preparation of dodecyl dimethyl naphthylmethyl ammonium glycyrrhizinate
Preparation of alkyl dimethyl naphthylmethyl ammonium hydroxide
Alkyl dimethyl naphthylmethyl ammonium hydroxide is prepared from the corresponding chloride (BTC 1100) supplied by Noury-Onyx NV. 98% of the alkyl chain of BTC 1100 is dodecyl.
The hydroxide of BTC 1100 is obtained in alcoholic solution by ion exchange starting from BTC 1100 by passing over a previously hydroxylated Dowex AG2-X8 column, such as described in Example II.
Preparation of glycyrrhizinate
8.4 g (0.01 mole) Glycamil are suspended in 20 ml pure ethyl alcohol; then 30.5 ml of a 0.066 N solution of hydroxide of BTC 1100 are added, after which dissolution occurs. This solution is then evaporated under vacuum.
Analysis:
The purity is determined by titration of the bound quaternary ammonium, expressed in milli-equivalent for 100 g product.
Found 130.2.
Calculated 130.4.
EXAMPLE IV.
Preparation of tetradecyl dimethyl benzyl ammonium glycyrrhizinate
Preparation of alkyl dimethyl benzyl ammonium hydroxide
Alkyl di methyl benzyl ammonium hydroxide is prepared from the corresponding chloride (BTC 824) supplied by Noury-Onyx NV. 93% of the alkyl chain of BTC 824 is tetradecyl.
The hydroxide of BTC 824 is obtained in alcoholic solution by ion exchange starting from BTC 824 by passing over a previously hydroxylated Dowex AG2--X8 column as hereinbefore described.
Preparation of glycyrrhizinate
8.4 g (0.01 mole) Glycamil are suspended in 20 ml pure ethyl alcohol; then 30.5 ml of a 0.066 N solution of BTC 824 hydroxide are added, after which dissolution occurs. This solution is evaporated under vacuum.
Analysis:
The purity is determined by titration of the bound quaternary ammonium, expressed in milli-equivalent for 100 g product.
Found 145.5.
Calculated 134.8.
EXAMPLE V.
Delltitric$ /r Alumina 43 Water 22.5
Hydroxyethyl cellulose 1.3
Glycerine 15 Sorbitol (90%) 16
Tween 20 (TWEEN is a trade mark) 0.5
Flavour 1.2
Tetradecyl trimethyl ammonium
glycyrrhizinate 0.5
EXAMPLE VI.
Dentifrice
Calcium carbonate 20
Dicalcium phosphate 28
Sorbitil (70%) 20
Hydroxyethyl cellulose 1.5
Tween 20 0.5
Flavour 1.1
Dodecyl dimethyl naphthylmethyl
ammonium glycyrrhizinate 0.5
Water 28.4
EXAMPLE VII.
Dentifrice
Dicalcium phosphate 3W Hydroxyethyl cellulose 1.3
Sorbitol (70%) 10
Glycerine 5
Tetradecyl trimethyl ammonium
glycyrrhizinate 0.5
Tween 60 0.5
Flavour 1.2
Water 31.5
EXAMPLE VIII.
Mouthwash
Tetradecyl dimethyl benzyl
ammonium glycyrrhizinate 0.1
Sorbitol 20
Distilled water 49.499
Tween 60 0.3
Bulgarian mint oil 0.05
Ceylon cinnamon oil 0.05
Red No. 2 (FD & C) 0.001
Alcohol BG 95"C 30
EXAMPLE IX.
Dentifrice %
Tetradecyl dimethyl benzyl
ammonium glycyrrhizinate 1.0
Humectant 27.0
Titanium dioxide 1.0
Emulsifier 1.5
Formalin (30%) 0.5
Alumina 55.0
Thickener 1.3
Water to 100
EXAMPLE X.
Dentifrice
Tetradecyl dimethyl benzyl
ammonium glycyrrhizinate 1.0
Humectant 27.0
Titanium dioxide 0.5
Emulsifier 1.5
Formalin (30%) 0.5
Alumina 50.0
Thickener 1.5
Water to 100
Claims (2)
- WHAT WE CLAIM IS:1. Compounds represented by the general formula:in which R1, R2 and R3 are each hydrogen or ammonium or a quaternary ammonium cation having the structure:in which R, R5 and RG are each a C1 30 straight or branched chain, saturated or un saturated acyclic hydrocarbon radical, or two or three of R4, Rb and R6 together with the adjacent nitrogen atom represent a pyridine, piperidine or morpholine radical, and R; is an alkyl, hydroxyalkyl, aryl, aralkyl, cyclohexyl or hydroxycyclohexyl radical, with the proviso that at least one of R1, R2 and R, is a quaternary ammonium cation having the above structure and not more than one of the radicals R1-R3 is ammonium.
- 2. A product for the care of the mouth comprising a compound according to claim 1 together with a physiologically acceptable diluent.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4965475A GB1567307A (en) | 1976-12-01 | 1976-12-01 | Salts of glycyrrhizinic acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4965475A GB1567307A (en) | 1976-12-01 | 1976-12-01 | Salts of glycyrrhizinic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1567307A true GB1567307A (en) | 1980-05-14 |
Family
ID=10453088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB4965475A Expired GB1567307A (en) | 1976-12-01 | 1976-12-01 | Salts of glycyrrhizinic acid |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB1567307A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3203310A1 (en) * | 1981-02-06 | 1982-12-02 | Biorex Laboratories Ltd | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ORAL DISEASES |
| US4415549A (en) | 1982-05-17 | 1983-11-15 | Richardson-Vicks Inc. | Toothpastes with reduced salinity |
| EP0067476A3 (en) * | 1981-06-11 | 1983-12-14 | Unilever N.V. | Dentifrice composition |
| DE3443242A1 (en) * | 1982-03-05 | 1986-05-28 | Yissum Res Dev Co | Glycyrrhizin and a medicament containing an active compound |
| US4918171A (en) * | 1987-07-23 | 1990-04-17 | Takeda Chemical Industries, Ltd. | Saikosaponin derivatives, their production and use |
| US5356880A (en) * | 1991-05-30 | 1994-10-18 | Sanwa Kagaku Kenkyusho Co., Ltd. | Glycyrrhetinic acid derivatives |
| WO2005110342A1 (en) * | 2004-05-14 | 2005-11-24 | Phenion Gmbh & Co. Kg | Use of ammonium salts of glycyrrhizinic acid and glycyrrhetinic acid for epilation |
-
1976
- 1976-12-01 GB GB4965475A patent/GB1567307A/en not_active Expired
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3203310A1 (en) * | 1981-02-06 | 1982-12-02 | Biorex Laboratories Ltd | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ORAL DISEASES |
| EP0067476A3 (en) * | 1981-06-11 | 1983-12-14 | Unilever N.V. | Dentifrice composition |
| DE3443242A1 (en) * | 1982-03-05 | 1986-05-28 | Yissum Res Dev Co | Glycyrrhizin and a medicament containing an active compound |
| GB2167296A (en) * | 1982-03-05 | 1986-05-29 | Yissum Res Dev Co | Topical pharmaceutical compositions containing glycyrrhizin |
| FR2573655A1 (en) * | 1982-03-05 | 1986-05-30 | Yissum Res Dev Co | Prepn. of glycyrrhizin and drug in aq. medium |
| US4415549A (en) | 1982-05-17 | 1983-11-15 | Richardson-Vicks Inc. | Toothpastes with reduced salinity |
| US4918171A (en) * | 1987-07-23 | 1990-04-17 | Takeda Chemical Industries, Ltd. | Saikosaponin derivatives, their production and use |
| US5356880A (en) * | 1991-05-30 | 1994-10-18 | Sanwa Kagaku Kenkyusho Co., Ltd. | Glycyrrhetinic acid derivatives |
| WO2005110342A1 (en) * | 2004-05-14 | 2005-11-24 | Phenion Gmbh & Co. Kg | Use of ammonium salts of glycyrrhizinic acid and glycyrrhetinic acid for epilation |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5370865A (en) | Composition for use in oral cavity | |
| US5451401A (en) | Diphosphonic acid esters as tartar control agents | |
| US4636382A (en) | Morpholino compounds and compositions | |
| EP0555864B1 (en) | Composition for use in oral cavity | |
| US5158763A (en) | Non-staining anti-bacterial oral composition | |
| JPS6043321B2 (en) | mouth freshener | |
| JPH05929A (en) | Liquid transparent oral composition | |
| WO1999029289A1 (en) | Stabilized oral compositions containing (n alpha-acyl-l-arginine) alkyl ester salts | |
| US4894221A (en) | Method of treating plaque using morpholine compounds | |
| DE69211155T2 (en) | PHYTATE-ANTIMICROBIAL COMPOSITIONS IN ORAL CARE PRODUCTS | |
| JP2002020253A (en) | Composition for oral use | |
| US4477429A (en) | Oral compositions comprising N.sup.α -alkyl derivatives of arginine | |
| GB1567307A (en) | Salts of glycyrrhizinic acid | |
| US4477428A (en) | Oral compositions comprising N.sup.α,NG -diacyl derivatives of arginine | |
| US4499068A (en) | Oral compositions comprising NG -alkyl derivatives of arginine | |
| CA1198738A (en) | Oral compositions comprising n.sup.g-acyl derivatives of arginine | |
| US4119711A (en) | Piperidino derivatives | |
| US3988435A (en) | Dihydrochalcone glycoside derivatives and pharmaceutical compositions containing same | |
| US3928618A (en) | Oral compositions | |
| IE43685B1 (en) | Piperidine derivatives and their use in compositions for the treatment of theeth and the oral cavity | |
| US4289753A (en) | Calculus-inhibiting method and compositions | |
| US4098879A (en) | N-alkyl-3-pyridinium-methanol fluorides and derivatives thereof | |
| US3639571A (en) | Composition and method for retarding plaque and dental calculus | |
| US3898284A (en) | Ether-linked quaternary ammonium compounds | |
| JPS5936882B2 (en) | Oral composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PCNP | Patent ceased through non-payment of renewal fee |